Long non‐coding RNA MRPL23‐AS1 suppresses anoikis in salivary adenoid cystic carcinoma in vitro.

Distant lung metastasis is the main factor that affects the survival rate of patients with salivary adenoid cystic carcinoma (SACC). Anoikis resistance is a feature of tumor cells that easily metastasize. The long non‐coding RNA (lncRNA) MRPL23 antisense RNA 1 (MPRL23‐AS1) is related to lung metastasis in SACC, but its role in anoikis resistance is unknown. After altering MPRL23‐AS1 expression in SACC cells, anoikis resistance was detected by calcein AM/PI staining and annexin V/PI flow cytometry. The apoptosis marker activated caspase‐3 and the bcl‐2/bax ratio were detected by Western blotting. The relationship between MPRL23‐AS1 and the promoter of the potential downstream target gene p19INK4D was identified by chromatin immunoprecipitation (ChIP)‐PCR assay. p19INK4D expression in patient tissues was determined using qRT‐PCR and immunohistochemistry. The functional experiments showed that MPRL23‐AS1 could promote anoikis resistance in vitro. MRPL23‐AS1 recruited the EZH2 to the promoter region of p19INK4D, inhibited p19INK4D expression, and promoted tumor cell anoikis resistance. p19INK4D overexpression did not affect anoikis in attached cells; however, it attenuated the anoikis resistance effect of MPRL23‐AS1 in suspension cells. p19INK4D expression was significantly lower in SACC tissues than in normal tissues. The novel MRPL23‐AS1/p19INK4D axis may be a potential SACC biomarker or therapeutic target. [ABSTRACT FROM AUTHOR]